Correlation Between MorphoSys and Replimune
Can any of the company-specific risk be diversified away by investing in both MorphoSys and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MorphoSys and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MorphoSys AG ADR and Replimune Group, you can compare the effects of market volatilities on MorphoSys and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MorphoSys with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of MorphoSys and Replimune.
Diversification Opportunities for MorphoSys and Replimune
Good diversification
The 3 months correlation between MorphoSys and Replimune is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding MorphoSys AG ADR and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and MorphoSys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MorphoSys AG ADR are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of MorphoSys i.e., MorphoSys and Replimune go up and down completely randomly.
Pair Corralation between MorphoSys and Replimune
Considering the 90-day investment horizon MorphoSys AG ADR is expected to under-perform the Replimune. In addition to that, MorphoSys is 3.91 times more volatile than Replimune Group. It trades about -0.18 of its total potential returns per unit of risk. Replimune Group is currently generating about 0.07 per unit of volatility. If you would invest 936.00 in Replimune Group on September 29, 2024 and sell it today you would earn a total of 290.00 from holding Replimune Group or generate 30.98% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 22.22% |
Values | Daily Returns |
MorphoSys AG ADR vs. Replimune Group
Performance |
Timeline |
MorphoSys AG ADR |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Replimune Group |
MorphoSys and Replimune Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MorphoSys and Replimune
The main advantage of trading using opposite MorphoSys and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MorphoSys position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.MorphoSys vs. Century Therapeutics | MorphoSys vs. Edgewise Therapeutics | MorphoSys vs. C4 Therapeutics | MorphoSys vs. Mineralys Therapeutics, Common |
Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |